ALG-125755
- Generic Name
- ALG-125755
A Study of ALG-125755 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single Doses in Healthy Volunteers, and Single and Multiple Doses in CHB Subjects
- First Posted Date
- 2022-09-30
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Aligos Therapeutics
- Target Recruit Count
- 57
- Registration Number
- NCT05561530
- Locations
- 🇧🇬
MBAL Sveta Sofia EOOD, Dept of Internal Medicine with Gastroenterology Section, Sofia, Bulgaria
🇲🇩PMSI Republican Clinical Hospital "t. Mosneaga", ARENSIA Exploratory Medicine Phase 1 Unit, Chisinau, Moldova, Republic of
🇳🇿New Zealand Clinical Research, Auckland, New Zealand
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath